HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,762,799 | -25.3% | 67,100 | -33.6% | 0.02% | -40.6% |
Q2 2023 | $10,390,730 | +10.5% | 101,028 | +17.2% | 0.03% | -15.8% |
Q1 2023 | $9,404,921 | -12.7% | 86,173 | -9.0% | 0.04% | -9.5% |
Q4 2022 | $10,779,136 | -19.1% | 94,720 | -56.0% | 0.04% | -37.3% |
Q3 2022 | $13,331,000 | -28.6% | 215,404 | -8.0% | 0.07% | -35.6% |
Q2 2022 | $18,677,000 | +14.7% | 234,163 | +51.3% | 0.10% | +48.6% |
Q1 2022 | $16,288,000 | -34.5% | 154,814 | -32.9% | 0.07% | +6.1% |
Q4 2021 | $24,880,000 | +233.1% | 230,883 | +189.4% | 0.07% | +135.7% |
Q2 2021 | $7,470,000 | -11.8% | 79,776 | -13.3% | 0.03% | -44.0% |
Q1 2021 | $8,473,000 | +3038.1% | 92,058 | +2392.1% | 0.05% | +2400.0% |
Q4 2020 | $270,000 | -96.7% | 3,694 | -96.5% | 0.00% | -98.2% |
Q3 2020 | $8,171,000 | +184.6% | 105,187 | +32.6% | 0.11% | +547.1% |
Q4 2019 | $2,871,000 | -58.7% | 79,311 | -68.9% | 0.02% | -72.6% |
Q3 2019 | $6,954,000 | -45.5% | 255,391 | -51.9% | 0.06% | -50.0% |
Q2 2019 | $12,767,000 | – | 530,648 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |